Alliqua Biomedical prices a $30 million offering for its hydrogel wound care products.
Alliqua Biomedical (NSDQ:ALQA) today said it priced a public stock offering worth $30 million for its hydrogel wound care technology.
The Langhorne, Pa.-based company said it plan to offer nearly 6.9 million shares at $4.55 apiece.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1dt4MkL
Cap comentari:
Publica un comentari a l'entrada